1 Citation
Summary
This metadata record provides details of the data supporting the claims of the related manuscript: “The genomic landscape of metastatic histologic special types of invasive breast cancer ”. The related study aimed to define the repertoire of somatic genetic alterations of metastatic histologic special types of breast cancer. The study re-analyzed targeted capture sequencing data of 309 special types of breast cancer, including metastatic and primary invasive lobular carcinomas (n=132 and n=127, respectively), mixed mucinous (n=5 metastatic and n=14 primary), micropapillary (n=12 metastatic and n=8 primary) and metaplastic breast cancers (n=6 metastatic and n=5 primary), and compared metastatic histologic special types of breast cancer to metastatic invasive ductal carcinomas of no special type (IDC-NSTs) matched according to clinicopathologic characteristics and to primary special type breast cancers.
Data accessThe data supporting the related study are as follows:- Histologic images supporting Figures 1, 2, 3, 4, and Supplementary Figure 7: these are not publicly available, but can be requested from the corresponding author, Dr. Fresia Pareja.- MSK-IMPACT sequencing data supporting Figures 1, 2, 3, 4, 5, Supplementary Figures 1, 2, 3, 4, 5, 6, and Supplementary Table 3, 4, 5: these data are publicly available in cBioPortal at the following accession: https://identifiers.org/cbioportal:breast_msk_2018 - Clinical data supporting supplementary Tables 1, 2, 5 and 6: these data are available in the original publication by Razavi et al (https://doi.org/10.1016/j.ccell.2018.08.008).
Corresponding authorDr. Fresia Pareja Memorial Sloan Kettering Cancer CenterDepartment of Pathology1275 York AvenueNew York, NY 10065United States212-639-3707parejaf@mskcc.org
Name of Institutional Review Board or ethics committee that approved the study
The study was approved by Memorial Sloan Kettering Cancer Center Institutional Review Board as part of the project whose findings were initially published by Razavi et al (2018). Informed consent was provided in the original study by Razavi et al “2018).
This metadata record provides details of the data supporting the claims of the related manuscript: “The genomic landscape of metastatic histologic special types of invasive breast cancer ”. The related study aimed to define the repertoire of somatic genetic alterations of metastatic histologic special types of breast cancer. The study re-analyzed targeted capture sequencing data of 309 special types of breast cancer, including metastatic and primary invasive lobular carcinomas (n=132 and n=127, respectively), mixed mucinous (n=5 metastatic and n=14 primary), micropapillary (n=12 metastatic and n=8 primary) and metaplastic breast cancers (n=6 metastatic and n=5 primary), and compared metastatic histologic special types of breast cancer to metastatic invasive ductal carcinomas of no special type (IDC-NSTs) matched according to clinicopathologic characteristics and to primary special type breast cancers.
Data accessThe data supporting the related study are as follows:- Histologic images supporting Figures 1, 2, 3, 4, and Supplementary Figure 7: these are not publicly available, but can be requested from the corresponding author, Dr. Fresia Pareja.- MSK-IMPACT sequencing data supporting Figures 1, 2, 3, 4, 5, Supplementary Figures 1, 2, 3, 4, 5, 6, and Supplementary Table 3, 4, 5: these data are publicly available in cBioPortal at the following accession: https://identifiers.org/cbioportal:breast_msk_2018 - Clinical data supporting supplementary Tables 1, 2, 5 and 6: these data are available in the original publication by Razavi et al (https://doi.org/10.1016/j.ccell.2018.08.008).
Corresponding authorDr. Fresia Pareja Memorial Sloan Kettering Cancer CenterDepartment of Pathology1275 York AvenueNew York, NY 10065United States212-639-3707parejaf@mskcc.org
Name of Institutional Review Board or ethics committee that approved the study
The study was approved by Memorial Sloan Kettering Cancer Center Institutional Review Board as part of the project whose findings were initially published by Razavi et al (2018). Informed consent was provided in the original study by Razavi et al “2018).